A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. The device includes a tube connecting the hollow flap to a cooling air source. The method may include receiving at least one macrocell pilot strength measurement or femtocell pilot or beacon strength measurement from the user device in response to the request.